These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11867860)

  • 1. Early diagnosis of Duchenne muscular dystrophy with high level of transaminases.
    Kurul S; Ulgenalp A; Dirik E; Ercal D
    Indian Pediatr; 2002 Feb; 39(2):210-1. PubMed ID: 11867860
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum transaminase levels in boys with Duchenne and Becker muscular dystrophy.
    McMillan HJ; Gregas M; Darras BT; Kang PB
    Pediatrics; 2011 Jan; 127(1):e132-6. PubMed ID: 21149430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duchenne muscular dystrophy: issues in expanding newborn screening.
    Kemper AR; Wake MA
    Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatigue, decreased interest in play, motor delay, and elevated liver function tests in a 4-year-old boy.
    Stein MT; Tipnis NA; Schultz P
    J Dev Behav Pediatr; 2002 Feb; 23(1):37-41. PubMed ID: 11889350
    [No Abstract]   [Full Text] [Related]  

  • 5. Natural History of Serum Enzyme Levels in Duchenne Muscular Dystrophy and Implications for Clinical Practice.
    Rodríguez-Cruz M; Almeida-Becerril T; Atilano-Miguel S; Cárdenas-Conejo A; Bernabe-García M
    Am J Phys Med Rehabil; 2020 Dec; 99(12):1121-1128. PubMed ID: 32520799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early diagnosis of Duchenne muscular dystrophy by means of non selective neonatal screening].
    Martín Fernandez-Mayoralas D; San Antonio-Arce V; Campos-Castelló J
    Rev Neurol; 2002 Sep 16-30; 35(6):595-6. PubMed ID: 12389180
    [No Abstract]   [Full Text] [Related]  

  • 7. Fatty liver disease and hypertransaminasemia hiding the association of clinically silent Duchenne muscular dystrophy and hereditary fructose intolerance.
    Paolella G; Pisano P; Albano R; Cannaviello L; Mauro C; Esposito G; Vajro P
    Ital J Pediatr; 2012 Oct; 38():64. PubMed ID: 23114028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valley sign in Becker muscular dystrophy and outliers of Duchenne and Becker muscular dystrophy.
    Pradhan S
    Neurol India; 2004 Jun; 52(2):203-5. PubMed ID: 15269471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminotransferases and muscular diseases: a disregarded lesson. Case reports and review of the literature.
    Veropalumbo C; Del Giudice E; Esposito G; Maddaluno S; Ruggiero L; Vajro P
    J Paediatr Child Health; 2012 Oct; 48(10):886-90. PubMed ID: 20500440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of disease progression on the neuromuscular blocking effect of mivacurium in children and adolescents with Duchenne muscular dystrophy.
    Ihmsen H; Schmidt J; Schwilden H; Schmitt HJ; Muenster T
    Anesthesiology; 2009 May; 110(5):1016-9. PubMed ID: 19352159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Increased troponin I level in a Duchenne muscular dystrophy patient with normal coronarography].
    Schoeffler M; Wallet F; Robert MO; Tramoni G; Workineh S; Viale JP; Duperret S
    Ann Fr Anesth Reanim; 2008 Apr; 27(4):345-7. PubMed ID: 18468552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missed opportunities for duchenne muscular dystrophy.
    Kaufmann P
    J Pediatr; 2009 Sep; 155(3):309-10. PubMed ID: 19732575
    [No Abstract]   [Full Text] [Related]  

  • 13. Short stature and high serum transaminase levels: growth hormone deficiency in a child with Becker muscular dystrophy.
    Gaudino R; Piona C; Morandi G; Maines E; Banzato C; Tonin P; Scarpelli M; Cavarzere P; Antoniazzi F
    Minerva Pediatr; 2017 Oct; 69(5):460-462. PubMed ID: 28745468
    [No Abstract]   [Full Text] [Related]  

  • 14. Duchenne muscular dystrophy: relevant paper was not included.
    Smith RA; Phillips RS
    BMJ; 2001 Nov; 323(7323):1253. PubMed ID: 11719423
    [No Abstract]   [Full Text] [Related]  

  • 15. Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy.
    Mayhew JE; Florence JM; Mayhew TP; Henricson EK; Leshner RT; McCarter RJ; Escolar DM
    Muscle Nerve; 2007 Jan; 35(1):36-42. PubMed ID: 16969838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eight novel microsatellite markers in the 3' region of the dystrophin gene useful for diagnosis of Duchenne muscular dystrophy.
    Matsumoto T; Niikawa N
    Prenat Diagn; 2004 Dec; 24(12):1014-5. PubMed ID: 15612059
    [No Abstract]   [Full Text] [Related]  

  • 17. Elevations of serum glutamic-oxalacetic transaminase and urinary coproporphyrins in pseudohypertrophic muscular dystrophy.
    RITTER JA; SELIGSON D
    Am J Med Sci; 1957 May; 233(5):559-62. PubMed ID: 13410932
    [No Abstract]   [Full Text] [Related]  

  • 18. Cognitive and psychological profile of males with Becker muscular dystrophy.
    Young HK; Barton BA; Waisbren S; Portales Dale L; Ryan MM; Webster RI; North KN
    J Child Neurol; 2008 Feb; 23(2):155-62. PubMed ID: 18056690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diagnosis of Duchenne/Becker muscular dystrophy: enhanced detection of dystrophin gene rearrangements by oligonucleotide array-comparative genomic hybridization.
    del Gaudio D; Yang Y; Boggs BA; Schmitt ES; Lee JA; Sahoo T; Pham HT; Wiszniewska J; Chinault AC; Beaudet AL; Eng CM
    Hum Mutat; 2008 Sep; 29(9):1100-7. PubMed ID: 18752307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electromyographic pattern in Duchenne and Becker muscular dystrophy. Part II. Electromyographic pattern in Becker muscular dystrophy in comparison with Duchenne muscular dystrophy.
    Emeryk-Szajewska B; Kopeć J
    Electromyogr Clin Neurophysiol; 2008; 48(6-7):279-84. PubMed ID: 18837193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.